Wipro Consumer Care invests unknown sum in women's health startup Gynoveda

Founded in 2019 by a husband-wife duo and a gynaecologist, Gynoveda attempts to help women aged 14-45-years cure disorders such as infertility, PCOS, and irregular menstrual cycles

Wipro
Peerzada Abrar Bengaluru
2 min read Last Updated : Mar 27 2023 | 3:04 PM IST
Wipro Consumer Care - Ventures, the venture capital arm of Wipro Consumer Care & Lighting, has invested an undisclosed sum in Gynoveda, a  startup focused on addressing women’s healthcare issues. These include gynaecological and lifestyle-related disorders faced by women from puberty to menopause.

Gynoveda was founded in 2019 by husband-wife duo Rachana and Vishal Gupta, along with gynaecologist Dr Aarati Patil. Its aim is to help women aged 14-45-years cure disorders such as infertility, PCOS, and irregular menstrual cycles, among other ailments.

“We believe there are large unaddressed needs of women who suffer and live with these problems where Gynoveda is already making a visible impact with their offerings as well as educational initiatives. The strong team of Vishal, Rachna and Aarti has all the elements to make Gynoveda formidable with the aim of reaching a larger population.” said Sumit Keshan, Managing Partner, Wipro Consumer Care - Ventures. “This is aligned with our interests in health and wellness space, in addition to our existing focus on personal care, fragrances, food and nutrition. This is the 10th investment from our fund.”

“Our philosophy is to solve gynecological disorders for women, without putting them on life-long medication. We can help them get rid of gynecological problems within 6-8 months or a year, based on their chronicity,” co-founder and CEO Vishal Gupta said. “Gynoveda has so far improved the health of 300,000 women residing in 20,000 pin codes of India,” he added.

The firm aims to tap the $9.6 billion global women’s healthcare industry. Gynoveda said it sells proprietary formulations certified by the United States Food and Drug Administration (FDA) and India’s National Accreditation Board for Testing and Calibration Laboratories. It sells these products via its website as well as e-commerce marketplaces such as Amazon, Flipkart and Nykaa. The firm said it also has strong initiatives on providing expert consultations thru tele-consultation mode, educational materials thru blogs and videos, and webinars.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Wipro Consumer CareWomen healthMenstrual healthCompanies

First Published: Mar 27 2023 | 2:58 PM IST

Next Story